BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 484805)

  • 1. [Effect of synthetic progestins with a varying estrogen dose on the blood coagulating properties].
    Rotkina IE; Lutsik LA; Stegnii NA
    Akush Ginekol (Mosk); 1979 Jul; (7):48-9. PubMed ID: 484805
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-morphological characteristics of endometriosis of different localization during treatment with synthetic progestins].
    Zheleznov BI; Strizhakov AN; Adamian LV
    Akush Ginekol (Mosk); 1979 May; (5):35-8. PubMed ID: 474901
    [No Abstract]   [Full Text] [Related]  

  • 3. [Incidence of side effects of synthetic progestins with different content of estrogenic and gestagenic components].
    Rotkina IE; Lutsik LA; Dubovik NT
    Akush Ginekol (Mosk); 1977 Sep; (9):29-31. PubMed ID: 596558
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of synthetic progestins on the content of sex chromatin in endometrial hyperplasia].
    Rotkina IE; Lutsik LA
    Akush Ginekol (Mosk); 1977 Jul; (7):33-5. PubMed ID: 900404
    [No Abstract]   [Full Text] [Related]  

  • 5. EFFECT OF SYNTHETIC ORAL GESTAGENS ON CERVICAL MUCUS AND SPERM PENETRATION.
    ZANARTU J
    Int J Fertil; 1964; 9():225-30. PubMed ID: 14106261
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood coagulation properties in patients with external endometriosis and their changes during infecundin treatment].
    Lutsik LA; Rotkina IE; Shunkova EI
    Akush Ginekol (Mosk); 1979 Oct; (10):41-2. PubMed ID: 507336
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
    Bonnar J; Daly L; Carroll E
    Int J Fertil; 1987; 32 Suppl():21-8. PubMed ID: 2906344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC; Montes MB; Franceschini SA; Toloi MR
    Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of progestins. Focus on the novel progestin drospirenone.
    Thorneycroft IH
    J Reprod Med; 2002 Nov; 47(11 Suppl):975-80. PubMed ID: 12497671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethinyl estradiol/drospirenone (Yasmin): a newer oral contraceptive.
    Somma MA
    Am Fam Physician; 2004 May; 69(10):2425-6. PubMed ID: 15168965
    [No Abstract]   [Full Text] [Related]  

  • 11. Estrogen-progesterone therapy for bleeding gastrointestinal telangiectasias in chronic renal failure. An uncontrolled trial.
    Bronner MH; Pate MB; Cunningham JT; Marsh WH
    Ann Intern Med; 1986 Sep; 105(3):371-4. PubMed ID: 3488703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of oral estrogen-progestin contraceptives on blood coagulation and assessment of the risk of thromboembolism].
    Surico N; Porcelli A; Petrelli P; Amedeo M; Crivello T; Ferraris G
    Minerva Ginecol; 1988 Sep; 40(9):559-62. PubMed ID: 2975773
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological aspects of oral contraceptives (author's transl)].
    Weil-levy C; Soubrie C; Simon P
    Contracept Fertil Sex (Paris); 1980 Feb; 8(2):123-7. PubMed ID: 12336185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of synthetic steroid preparations for hemostasis and normalization of menstrual function in juvenile hemorrhages].
    Kuznetsova MN; Antipina NN; Zagorskaia EA
    Vopr Okhr Materin Det; 1978 Feb; 23(2):77-80. PubMed ID: 347706
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
    Sabra A; Bonnar J
    J Reprod Med; 1983 Jan; 28(1 Suppl):85-91. PubMed ID: 6834350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in coagulation and fibrinolysis variables during use of two oral contraceptives containing the same dose of ethinyl estradiol and either gestodene or desogestrel.
    Gevers Leuven JA; Kluft C; Dersjant-Roorda MC; Harthoorn-Lasthuizen EJ; Peters FP; Bernsen MJ; Helmerhorst FM
    Adv Contracept; 1990 Dec; 6 Suppl():69-73. PubMed ID: 2149807
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of the effect of ethinyl estradiol and mestranol. Clinical data from the literature].
    Pellegrini R; Seassaro E
    Quad Clin Ostet Ginecol; 1969 Sep; 24(9):597-617. PubMed ID: 4926507
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytological check-up on the effectiveness of the hormonal treatment of endometriosis].
    Kopecný J; Kopecná V
    Cesk Gynekol; 1973; 38(1):38-9. PubMed ID: 4729366
    [No Abstract]   [Full Text] [Related]  

  • 20. [Endocervical epithelial changes in internal uterine endometriosis treated with bisekurin].
    Sabsaĭ MI; Kravchuk TA
    Akush Ginekol (Mosk); 1980 Oct; (10):43-4. PubMed ID: 7446855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.